BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11309382)

  • 1. Inhibition of c-Abl tyrosine kinase activity by filamentous actin.
    Woodring PJ; Hunter T; Wang JY
    J Biol Chem; 2001 Jul; 276(29):27104-10. PubMed ID: 11309382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotic phosphorylation rescues Abl from F-actin-mediated inhibition.
    Woodring PJ; Hunter T; Wang JY
    J Biol Chem; 2005 Mar; 280(11):10318-25. PubMed ID: 15632178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity.
    Van Etten RA; Jackson PK; Baltimore D; Sanders MC; Matsudaira PT; Janmey PA
    J Cell Biol; 1994 Feb; 124(3):325-40. PubMed ID: 8294516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension.
    Woodring PJ; Litwack ED; O'Leary DD; Lucero GR; Wang JY; Hunter T
    J Cell Biol; 2002 Mar; 156(5):879-92. PubMed ID: 11864995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of long and winding nuclear F-actin bundles by nuclear c-Abl tyrosine kinase.
    Aoyama K; Yuki R; Horiike Y; Kubota S; Yamaguchi N; Morii M; Ishibashi K; Nakayama Y; Kuga T; Hashimoto Y; Tomonaga T; Yamaguchi N
    Exp Cell Res; 2013 Dec; 319(20):3251-68. PubMed ID: 24041959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases.
    Woodring PJ; Hunter T; Wang JY
    J Cell Sci; 2003 Jul; 116(Pt 13):2613-26. PubMed ID: 12775773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse.
    Huang Y; Comiskey EO; Dupree RS; Li S; Koleske AJ; Burkhardt JK
    Blood; 2008 Jul; 112(1):111-9. PubMed ID: 18305217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Abl-related gene (Arg) nonreceptor tyrosine kinase uses two F-actin-binding domains to bundle F-actin.
    Wang Y; Miller AL; Mooseker MS; Koleske AJ
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14865-70. PubMed ID: 11752434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase.
    Glover RT; Angiolieri M; Kelly S; Monaghan DT; Wang JY; Smithgall TE; Buller AL
    J Biol Chem; 2000 Apr; 275(17):12725-9. PubMed ID: 10777567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity.
    Wen ST; Van Etten RA
    Genes Dev; 1997 Oct; 11(19):2456-67. PubMed ID: 9334312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization.
    Master Z; Tran J; Bishnoi A; Chen SH; Ebos JM; Van Slyke P; Kerbel RS; Dumont DJ
    J Biol Chem; 2003 Aug; 278(32):30170-9. PubMed ID: 12777393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration.
    Hu H; Bliss JM; Wang Y; Colicelli J
    Curr Biol; 2005 May; 15(9):815-23. PubMed ID: 15886098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA; Debnath J; Zhou H; Casasnovas JM
    Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abelson kinase acts as a robust, multifunctional scaffold in regulating embryonic morphogenesis.
    Rogers EM; Spracklen AJ; Bilancia CG; Sumigray KD; Allred SC; Nowotarski SH; Schaefer KN; Ritchie BJ; Peifer M
    Mol Biol Cell; 2016 Aug; 27(16):2613-31. PubMed ID: 27385341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Abl is involved in the F-actin assembly triggered by L-selectin crosslinking.
    Chen C; Ba X; Xu T; Cui L; Hao S; Zeng X
    J Biochem; 2006 Aug; 140(2):229-35. PubMed ID: 16840500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.
    Muller AJ; Pendergast AM; Parmar K; Havlik MH; Rosenberg N; Witte ON
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3457-61. PubMed ID: 7682703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function.
    Grover P; Shi H; Baumgartner M; Camacho CJ; Smithgall TE
    PLoS One; 2015; 10(7):e0133590. PubMed ID: 26222440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.